User profiles for PM O'Byrne

Paul O'Byrne

Professor, McMaster University
Verified email at mcmaster.ca
Cited by 70978

Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults

…, PH Quanjer, DW Cockcroft, PM O'Byrne… - European …, 1993 - Eur Respiratory Soc
Asthma and chronic obstructive pulmonary disease (COPD, also called chronic airflow limitation
(CAL)) are the most frequent diagnoses in patients with intrathoracic airways ob truction […

Treatment of asthma with drugs modifying the leukotriene pathway

JM Drazen, E Israel, PM O'Byrne - New England Journal of …, 1999 - Mass Medical Soc
In 1979 and 1980, the chemical structures of the material previously known as slow-reacting
substance of anaphylaxis were elucidated as 5(S)- hydroxy- 6(R)-glutathionyl- 7,9-trans-11,…

A summary of the new GINA strategy: a roadmap to asthma control

…, RF Lemanske, ML Levy, PM O'Byrne… - European …, 2015 - Eur Respiratory Soc
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …

Development and validation of a questionnaire to measure asthma control

EF Juniper, PM O'byrne, GH Guyatt… - European respiratory …, 1999 - Eur Respiratory Soc
International guidelines on asthma management indicate that the primary goal of treatment
should be optimum asthma control. The aim of this study was to develop and validate the …

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials …

…, SC Lazarus, ML Levy, PM O'Byrne… - American journal of …, 2009 - atsjournals.org
Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

[HTML][HTML] Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

…, E Pizzichini, FE Hargreave, PM O'Byrne - … England Journal of …, 2009 - Mass Medical Soc
Background Eosinophilic inflammation, which may be a consequence of interleukin-5 action,
is a characteristic feature of some forms of asthma. However, in three previous clinical trials …

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

…, SV Ohlsson, A Ullman, CJ Lamm, PM O'Byrne - The Lancet, 2003 - thelancet.com
… RA Pauwels, WW Busse, WC Tan, and PM O'Byrne have acted as a consultant for several
pharmaceutical companies including AstraZeneca and have spoken at meetings sponsored …

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

PM O'BYRNE, PJ Barnes… - American Journal of …, 2001 - atsjournals.org
The optimal treatment for mild asthma is uncertain. We assessed the effects of adding a long-acting
inhaled beta-agonist, formoterol, to low doses of an inhaled corticosteroid, …

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

PM O'Byrne, H Bisgaard, PP Godard… - American journal of …, 2005 - atsjournals.org
Asthma control is improved by combining inhaled corticosteroids with long-acting β 2 -agonists.
However, fluctuating asthma control still occurs. We hypothesized that in patients …

[HTML][HTML] Effects of an anti-TSLP antibody on allergen-induced asthmatic responses

GM Gauvreau, PM O'Byrne, LP Boulet… - … England Journal of …, 2014 - Mass Medical Soc
Background Thymic stromal lymphopoietin (TSLP) is an epithelial-cell–derived cytokine that
may be important in initiating allergic inflammation. AMG 157 is a human anti-TSLP …